First-ever AI-designed vaccine reaches human trials

A first-ever AI-designed vaccine targeting all coronaviruses and animal-borne strains has entered human trials. Initial safety tests with 39 participants succeeded, and larger efficacy studies are planned. The vaccine uses AI to create a 'super-antigen' for broad immunity, potentially reducing the need for frequent flu vaccine updates.